OrthoNovis received FDA 510(k) clearance to market its BPS Wrist Fracture System. The clearance authorizes OrthoNovis to market a line of locking wrist plates designed to fixate certain fractures, fusions or osteotomies in the distal radius.
“This milestone will allow OrthoNovis to compete in the rapidly growing US orthopedic fracture fixation market,” says Ken West, President and CEO. “Our BPS Wrist Fracture System is a critical step in the build-out of our complete line of orthopedic implants featuring our patented technologies and financially responsible pricing. We are well positioned to grow and will be releasing several new product lines that will address the treatment and fixation of commonly performed Orthopaedic procedures.”
OrthoNovis received FDA 510(k) clearance to market its BPS Wrist Fracture System. The clearance authorizes OrthoNovis to market a line of locking wrist plates designed to fixate certain fractures, fusions or osteotomies in the distal radius.
"This milestone will allow OrthoNovis to compete in the rapidly growing US orthopedic fracture fixation...
OrthoNovis received FDA 510(k) clearance to market its BPS Wrist Fracture System. The clearance authorizes OrthoNovis to market a line of locking wrist plates designed to fixate certain fractures, fusions or osteotomies in the distal radius.
“This milestone will allow OrthoNovis to compete in the rapidly growing US orthopedic fracture fixation market,” says Ken West, President and CEO. “Our BPS Wrist Fracture System is a critical step in the build-out of our complete line of orthopedic implants featuring our patented technologies and financially responsible pricing. We are well positioned to grow and will be releasing several new product lines that will address the treatment and fixation of commonly performed Orthopaedic procedures.”
Copy to clipboard 
